In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-22 of 22 for your search:
Drug:  raltitrexed
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 to5
Sponsor: Pharmaceutical / Industry
Protocol IDs: 1839IL/0143, NCT00234429

2.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Not specified
Sponsor:
Protocol IDs: MRC-CR06, EU-96049, NCT00002893

3.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: EORTC-40962, PETACC-1

4.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: Other
Protocol IDs: EORTC-08983, NCT00004920

5.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: E-6293, E6293

6.

Phase: Phase II
Type: Treatment
Status: Completed
Age: adult
Sponsor: NCI
Protocol IDs: SWOG-9519

7.

Phase: Phase II
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: NCCTG-935251, NCCTG-93-52-51

8.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 15-75
Sponsor: Pharmaceutical / Industry
Protocol IDs: EORTC-62951

9.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: Other
Protocol IDs: EORTC-08992, NCT00004254

10.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: MSKCC-93019, NCI-V93-0246

11.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: GOG-146B

12.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor:
Protocol IDs: NCI-93-C-0164, NCI-NMOB-9301

13.

Phase: Phase II
Type: Treatment
Status: Temporarily closed
Age: 18 to 75
Sponsor: Other
Protocol IDs: 0329-1ghfr09, NCT01348412

14.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 12 and under
Sponsor: NCI
Protocol IDs: NCI-93-C-021O, NCI-T93-0109N, T93-0109

15.

Phase: Phase I
Type: Treatment
Status: Closed
Age: under 21
Sponsor: NCI
Protocol IDs: POG-9379

16.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MSKCC-95021A4, ZENECA-MSKCC-95021A4, NCI-V96-0987, NCT00002828

17.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor:
Protocol IDs: CAN-NCIC-IND98, NCI-V96-1066, IND98

18.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000065242, UPCC-T96-0063, JMC-T96-0063, NCI-T96-0063O, T96-0063, NCT00002902

19.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MAYO-960104, NCI-T96-0083, T96-0083

20.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000065851, P30CA006927, FCCC-96116, NCI-T96-0113, T96-0113, NCT00003109

21.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI
Protocol IDs: NCI-2012-01839, 9779, U01CA097452, CDR0000066575, POG-9779, NCT00003528

22.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-91-C-177D, NCI-MB-275, NCI-T91-0121N, T91-0121
New Search